Robert A. Bradway

Amgen posted Q1 adjusted EPS of $5.15, beating consensus $4.80, and revenue of $8.62 bn, up 6% YoY. FY2026 guidance targets EPS $21.70‑$23.10 (mid $22.40) and revenue $37.1‑$38.5 bn (mid $37.8 bn), ne

Amgen reported adjusted EPS of $5.15, topping consensus $4.80 by $0.35. Revenue reached $8.62 billion, slightly above $8.59 billion estimate and up 6% YoY from $8.15 billion in Q1 2025. R&D expenses r